A healthcare device maker looks like a steady long-term add for someone trying to spread risk beyond big drug companies, helped by a recent buyout that broadens its brain-related tech offerings. The appeal is slow-and-steady growth and a long history of raising its payout, though the outlook isn’t flashy and some experts sound cautious.Read more

Verizon has been a long-time watchlist name, but recent signs of steadier results and a reliable dividend finally make it feel like a calmer way to balance a portfolio. The catch is timing: the stock can swing after you buy, so the plan is to start small, watch how it trades, and add gradually if it pulls back.Read more

I invested a lot in PSEC starting with a few hundred shares at average price of around $7 mid 2022. As we all know it's share price dropped to almost the level of a penny share.Read more

ABOUT THE INVESTOR I am a Western European private value investor with over 30 years of investment experience—experience that came with many “tuition fees.” Over time, however, one learns how, when, and in what to invest. Successful investing is about knowledge: solid fundamental and technical analysis, a focus on sustainable growth, prudent use of debt, strong competitive moats, insider behavior, dividend reinvestment, and continuous reading and study.Read more

Company overview Hydratec Industries is a Dutch small-cap industrial holding company operating through two strategic divisions: Industrial System , Focused on Food, Health, and Mobility, and High-Tech Components, Supplier of advanced plastic components that replace metal parts, enabling significant weight and cost reductions. The company has a long-term growth profile supported by strong market demand across its end markets.Read more

23-apr-2025 Novo Nordisk will face competition in the obisitas and diabetes space. Regulation and insurances may impact its growth.Read more